Revvity Stock - Weekly review and sector context

Revvity stock closed the week with a modest gain while investors weighed the diagnostics and life-sciences group against broader health-care peers and the Nasdaq. Analyst ratings remain constructive, but the shares still lag some sector benchmarks.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 20:30 UTC. Details in the imprint.

Revvity (US76155R1086) is drawing comparative attention at the end of the trading week as investors look at how the diagnostics and life-sciences group stacks up against health-care peers and the Nasdaq composite. The focus this Friday is on the weekly performance picture and sector backdrop.

How Revvity performed this week

Revvity shares finished Friday’s session around $100.00, according to real-time quote data for ticker RVTY, implying a gain of just over 2% on the day and a modest positive finish for the week overall.

That daily move still leaves the stock trading below many analyst price targets clustered in the low to mid-$110s, which suggests some catch-up potential if execution and market sentiment remain supportive.

Comparison with sector and Nasdaq

Over recent months, Revvity stock has lagged the broader Nasdaq composite, which continues to be driven by heavy technology and AI exposure rather than health care and diagnostics names.

Within the health-care and life-science tools universe, Revvity competes with diversified players exposed to diagnostics, analytics and lab instrumentation, where valuation multiples have been compressed by cautious spending patterns from pharma and academic customers.

The product behind the business

Revvity generates revenue from a mix of diagnostics and life-science tools, including instruments, reagents and software platforms used in areas such as genomics, imaging and disease screening for clinical and research customers worldwide.

Where the stock trades today

Revvity shares (US76155R1086) trade on the New York Stock Exchange at $100.00 as of 06/19/2026, 20:15 UTC.

Key facts on Revvity stock

• Company: Revvity Inc.
• ISIN: US76155R1086
• WKN: A3E5NA
• Ticker: RVTY
• Venue: NYSE
• Price (as of 06/19/2026, 20:15 UTC): 100.00 USD
• Market cap: 12,000,000,000 USD (as of 06/19/2026)
• Sector / Industry: Health Care - Life Sciences Tools & Services
• Index membership: Standard & Poor's 500 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.